Kyverna Therapeutics Extends Series B Financing Round To $145 Million And Brings In New Investors
Round Type
Series B
EmeryvilleBiotechnologyHealth CareScience And EngineeringInvestors
Description
Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune diseases, today announced the close of an oversubscribed $60 million Series B financing round extension, bringing the total Series B financing round to $145 million. New investors, Bain Capital Life Sciences and GordonMD® Global Investments LP, join existing investors Gilead Sciences, Westlake Village BioPartners, Vida Ventures, Northpond Ventures, RTW Investments, Insight Partners, CAM Capital, LYFE Capital, jVen Capital, and others.
Quick answer
Kyverna Therapeutics raised an undisclosed amount in a Series B round, dated August 3, 2023. Investors: J Ven Capital, LYFE Capital, CAM Capital, Insight Partners, RTW Investments, Northpond Ventures, Vida Ventures and Westlake Village Bio Partners. Kyverna Therapeutics is based in Emeryville, California, United States.
- How much did Kyverna Therapeutics raise?
- Kyverna Therapeutics raised an undisclosed amount in a Series B round on August 3, 2023.
- Who invested in Kyverna Therapeutics?
- J Ven Capital, LYFE Capital, CAM Capital, Insight Partners, RTW Investments, Northpond Ventures, Vida Ventures and Westlake Village Bio Partners are named as investors in this round.
- What does Kyverna Therapeutics do?
- Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
- Where is Kyverna Therapeutics based and how big is it?
- Kyverna Therapeutics is based in Emeryville, California, United States. Fundz records about 120 employees.
- Who are the decision-makers at Kyverna Therapeutics?
- Fundz holds 1 contact at Kyverna Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Kyverna Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Trait Biosciences Inc. raised $3.7M (Series A) on September 12, 2023.
- Advanced NanoTherapies raised $4M (Seed) on August 22, 2023.
- Viome raised $87M (Funding Round) on August 18, 2023.
- RedHill Biopharma Ltd raised $2.7M (Seed) on July 21, 2023.
- Septerna raised $73M on June 28, 2023.
- Nephron Pharmaceuticals raised $350M (Funding Round) on September 15, 2023.
Who to call at Kyverna Therapeutics, and when
A new round usually means Kyverna Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kyverna Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kyverna Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kyverna Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kyverna Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKyverna Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.